Home > Income Statement > NGL FINECHEM

NGL FINECHEM
Revenue

    Back to Income Statement
NGL FINECHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹368 Cr₹339 Cr₹278 Cr₹318 Cr₹258 Cr

What is the latest Revenue of NGL FINECHEM ?

The latest Revenue ratio of NGL FINECHEM is ₹368 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹368 Cr
Mar2025₹339 Cr
Mar2024₹278 Cr
Mar2023₹318 Cr
Mar2022₹258 Cr

How is Revenue of NGL FINECHEM Trending?

Years Revenue % Change
Mar2026 ₹368 Cr
8.73
Mar2025 ₹339 Cr
21.79
Mar2024 ₹278 Cr
-12.42
Mar2023 ₹318 Cr
23.08
Mar2022 ₹258 Cr -

Compare Revenue of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹1,775.0 Cr -5.3% -10.4% 113.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹458,249.0 Cr 1.8% -1.6% 16.5% Stock Analytics
DIVIS LABORATORIES ₹225,648.0 Cr -1.2% 17.3% 38.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹184,891.0 Cr -2.3% -2% 33.6% Stock Analytics
CIPLA ₹115,927.0 Cr 0.2% 1.7% -8.8% Stock Analytics
DR REDDYS LABORATORIES ₹99,702.0 Cr 1.2% 3.6% -7% Stock Analytics


NGL FINECHEM Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

-5.3%

-10.4%

113.7%

SENSEX

-0.5%

1.3%

-4%


You may also like the below Video Courses